Publication number: 20120171126
Abstract: The present invention provides compounds of Formula (I), and pharmaceutically acceptable salts, solvates, esters, prodrugs, tautomers, or isomers of said compounds), having the general structure: Formula (I) wherein L, R1, R2, R3, R4, R5, and R6 are selected independently of each other and as defined herein. The present invention also provides compounds (and salts, solvates, esters, prodrugs, tautomers, and isomers) of Formulas (H-A), (II-A1), (II-A2), (II-A2.1), (ll-A-2.2), (ll-A-2.3), (II-A4), (H-B), (H-C), (III), (IV), (V), (VI), as described herein. Also provided are pharmaceutical compositions, methods of preparing, and methods of using such compounds in the treatment and prophylaxis of a wide range of immune, autoimmune, and inflammatory diseases and conditions.
Type:
Application
Filed:
June 15, 2010
Publication date:
July 5, 2012
Inventors:
Biju J. Purakkattle, Michael Y. Berlin, Yeon-Hee Lim, Rema D. Bitar, Kevin D. McCormick, Robert G. Aslanian, Yoon Joo Lee, Junying Zheng, Ying Huang, Walter Won